A centralised HTA programme to improve market access

Systematic literature review of costs of stroke in patients with type 2 diabetes mellitus in six countries

Our client needed a trusted partner to coordinate a centralised HTA programme to gain market access for their product for the treatment of a rare neuromuscular disease in >20 EMEA markets.

Learn how Clarivate became a key decision making partner helping the client to secure many reimbursements in their chosen markets.